2018
$191M
from 13 investors over 13 rounds
Maze Therapeutics raised $190M on January 10, 2022
Investors: NS Investment, General Catalyst, Casdin Capital, LLC, Foresite Capital, City Hill Ventures, Driehaus Capital Management LLC and Woodline Partners LP
Maze Therapeutics raised undisclosed on October 23, 2019
Investors: City Hill Ventures
Maze Therapeutics raised $191M on February 28, 2019
Investors: Casdin Capital, LLC, ARCH Venture Partners, GV, Third Rock Ventures and Foresite Capital